The EHRC 2024 Sessions: 6. Drug Consumption Rooms in Europe  | 6th European Harm Reduction Conference, 2024

The EHRC 2024 Sessions: 6. Drug Consumption Rooms in Europe | 6th European Harm Reduction Conference, 2024

For more than 30 years, Drug Consumption Rooms (DCRs) have been implemented in Western countries. These services, typically aim to reduce overdose-related morbidity and mortality, prevent the spread of infectious diseases and provide access to a broad range of medical and social support services. As frontline, low-threshold services, DCRs are also often among the first sites where insights into new drug use patterns and they therefore play an important role in the early identification of new and emerging drug trends. In addition, DCRs may also have the objective of reducing drug use in public and to improve public amenities.
In some countries, DCRs are a well-established and integrated component in responses to drug-related problems. Additionally, a substantial body of practical experience and research evidence has accumulated to support its effectiveness in achieving public health and safety. Yet, the scale of DCR implementation still varies considerably worldwide as they remain contested measures, particularly at the level of political and public debates.
From a legal point of view, international conventions allow flexibility in the establishment of DCRs when national legislation acknowledges these facilities as part of a public health, harm-reduction strategy. However, in many countries, the operation and continuity of DCRS require adaptations to their legislative, judicial and/or administrative frameworks. Also, they face multiple political, cultural, economic and ethical obstacles, as well as community and public opinion debates.
This session aims to contribute to an informed discussion about DCRs, by presenting the available evidence, reviewing the various models being adopted and their characteristics, as well as (legal) preconditions and considerations that would allow this public health service to be integrated and balanced continuum of drug policy initiatives.
Potential partners: European Network of Drug Consumption Rooms, Queen’s University, EMCDDA, EuroNPUD
Moderator: Roberto Perez Gayo
Discussant: Peter Krykant, Release Drugs, Trustee
Subsessions
Abrigado Luxemburg 20+1: From drug consumption room to complex drug help center
December 03, 2024 9:00 AM – 9:10 AM
Implementation and development of an integrated model of Drug Consumption Room in a disadvantaged and stigmatized social housing context in Lisbon
December 03, 2024 9:10 AM – 9:20 AM
Overcoming legal barriers to the establishment of DCRs in Europe
December 03, 2024 9:20 AM – 9:30 AM
OPC Prep: Developing a core outcome set to evaluate overdose prevention centres (OPCs) or Drug Consumption Rooms (DCRs)
December 03, 2024 9:30 AM – 9:40 AM
Overdose prevention centres as spaces of safety, trust and inclusion: a causal pathway based on a realist review
December 03, 2024 9:40 AM – 9:50 AM
Drug Consumption Rooms operating in Greece: Highlighting the importance through evidence-based data.
December 03, 2024 9:50 AM – 10:00 AM


Drugreporter (EN): https://www.drugreporter.net/ Facebook (HU): https://www.facebook.com/drogriporter/ Facebook (EN): https://www.facebook.com/drugreporter/ Instagram (HU): https://www.instagram.com/drogriporter/ Instagram (EN): https://www.instagram.com/rrfdrugreporter/ X.com (EN): https://x.com/RRFdrugreporter TikTok (EN): https://www.tiktok.com/@drugreporter_rrf/ Bluesky (EN): https://www.bsky.app/profile/drugreporter.bsky.social/ A Jogriporter Alapítvány: https://www.jogriporter.hu/ The Rights Reporter Foundation: https://www.rightsreporter.net/

Denne episoden er hentet fra en åpen RSS-feed og er ikke publisert av Podme. Den kan derfor inneholde annonser.

Episoder(123)

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

ROBERT JESSE | The value of community can help psychedelics move into mainstream culture

At ICPR 2024, we talked to Robert Jesse, from the Johns Hopkins University, about mystical experiences with psychedelics, their spiritual and cultural dimensions, and the value of community in support...

18 Sep 27min

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

LEONIE SCHNEIDER, BSC & IAN ROULLIER, MA | We need compassionate access to psychedelic treatment

At ICPR 2024, we talked to Leonie Schneider and Ian Roullier, co-founders and co-directors of the Psychedelic Participant Advocacy Network (PsyPAN) in the UK, about why patient voices matter in the de...

18 Sep 21min

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelics: Saving Lives and Transforming Health Care – Interview with Tomáš Páleníček, MD, PhD

Psychedelic research in the Czech Republic has a long and distinguished history. At ICPR 2026, we spoke with psychiatrist and neuroscientist Tomáš Páleníček about clinical research, altered states of ...

18 Sep 26min

WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

WIM VAN DEN BRINK | Psychedelics help reduce compulsive thinking, such as craving in drug addiction

At ICPR 2024, we talked to Wim van den Brink, MD, PhD, Professor of Psychiatry and Addiction at the Academic Medical Center, University of Amsterdam, about the potential of psychedelics to reduce comp...

31 Aug 29min

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

Psychedelics: The State of the Science in 2026 – Interview with Sandeep Nayak, MD

What actually makes psychedelic therapy work? Is it the drug, the therapeutic setting, or the human relationship between therapist and participant? At ICPR 2026, we spoke with psychiatrist and researc...

31 Aug 33min

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

NICOLAS LANGLITZ, MD, PHD: You have to find a space for these wild psychedelics in a rule governed world

At ICPR 2024, we talked to anthropologist and author Nicolas Langlitz about the current hype around psychedelics, their place in medicine and culture, and why he sees them as holding the promise of mo...

31 Aug 29min

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Psychedelics and the Female experience – Interview with Grace Blest-Hopley, PhD

Women make up more than half of the population, yet they remain significantly underrepresented in psychedelic research. At ICPR 2026, we spoke with neuroscientist Grace Blest-Hopley about the gender g...

31 Aug 31min

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

MARC B. AIXALÀ: Bad trips can transform into potentially positive outcomes

At ICPR 2024, we talked to psychologist and psychotherapist Marc B. Aixalà about how so-called “bad trips” can be reframed as difficult but potentially transformative experiences, and the importance o...

26 Mai 16min

Populært innen Politikk og nyheter

giver-og-gjengen-vg
aftenpodden
popradet
aftenpodden-usa
bt-dokumentar-2
forklart
stopp-verden
det-store-bildet
nokon-ma-ga
fotballpodden-2
rss-gukild-johaug
dine-penger-pengeradet
rss-espen-lee-usensurert
hanna-de-heldige
rss-ness
rss-penger-polser-og-politikk
aftenbla-bla
frokostshowet-pa-p5
e24-podden
ta-dokumentar